tbuckley/cabot-search huggingface dataset:
In Vivo Analysis of PML-RARA in a Humanized Mouse Model
Authors: Hiromichi Matsushita, Takashi Yahata, Yin Sheng, Yoshihiko Nakamura, Yukari Muguruma, Hideyuki Matsuzawa, Masayuki Tanaka, Hideki Hayashi, Tadayuki Sato, Anar Damdinsuren, Makoto Onizuka, Mamoru Ito, Hayato Miyachi, Pier Paolo Pandolfi, Kiyoshi Ando
Journal: Blood (2014)
Role of Daunorubicin Dose Intensification for Induction Therapy in Acute Myeloid Leukemia Patients with FLT3-ITD Mutants
Authors: Eun-Ji Choi, Je-Hwan Lee, Jung-Hee Lee, Han-Seung Park, Sun-Hye Ko, Miee Seol, Ji Min Woo, Kyoo-Hyung Lee
Journal: Blood (2016)
Successive Development of T-Cell Acute Lymphoblastic Leukemia, Non-Langerhans-Cell Histiocytose and Histiocytic Sarcoma with a Common Origin: Evidence for Common Oncogenetic Transformation Before Full Lineage Commitment,
Authors: D. Maroeska W.M. te Loo, Esmé Waanders, Patricia JTA Groenen, Annet Simons, Jacques J.M. van Dongen, Peter M. Hoogerbrugge, Konnie M Hebeda
Journal: Blood (2011)
Cross-Platform Assessment Of Genomic Imbalance In Diffuse Large B-Cell Lymphoma Identifies Novel Candidate Loci and Genes With Prognostic Value and Roles In Lymphomagenesis
Authors: Lizalynn Dias, Venkata Thodima, Geetu Mendiratta, Guttapalli Asha, Camille Gonzalez, Jocelyn C. Maragulia, Andrew D. Zelenetz, Julie Teruya Feldstein, Raju S.K. Chaganti, Jane Houldsworth
Journal: Blood (2013)
BCL-2/IgH PCR Values at the End of Induction Treatment Are Not Predictive for Progression Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized Phase III Intergroup Trial.
Authors: Bert A. van der Reijden, Marinus H.J Van Oers, Evelyn Tonissen, Martine Van Glabbeke, Livia Giurgia, Richard Klasa, Robert E. Marcus, Max Wolf, Mars Van t Veer, Andrej Vranovsky, Harald Holte, Eva Kimby, Anton Hagenbeek
Journal: Blood (2007)
The Bcr-Abl SH2-Kinase Domain Interface Is Critical for Leukemogenesis and An Additional Therapeutic Target in CML.
Authors: Oliver D. Hantschel, Florian Grebien, Ines Kaupe, Boris Kovacic, John Wojcik, Gerald D Gish, Shohei Koide, Hartmut Beug, Tony Pawson, Giulio Superti-Furga
Journal: Blood (2009)
Involvement of Tumor Necrosis Factor Receptor Type II in <i>FoxP3</i> Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis
Authors: François Santinon, Maxime Batignes, Majda Lyna Mebrek, Jerôme Biton, Gaëlle Clavel, Roxane Hervé, Delphine Lemeiter, Magali Breckler, Florence Busato, Jorg Tost, Marianne Ziol, Marie‐Christophe Boissier, Patrice Decker, Luca Semerano, Natacha Bessis
Journal: Arthritis & Rheumatology (2019)

Objective To study the involvement of Treg cells expressing tumor necrosis factor receptor type II (TNFRII) in exerting control of inflammation in experimental models and in the response to anti‐ TNF treatments in patients with rheumatoid arthritis ( RA ) or spondyloarthritis (SpA). Methods The role of TNFRII in Treg cells was explored using a multilevel translational approach. Treg cell stability was evaluated by analyzing the methylation status of the Foxp3 locus using bisulfite sequencing. Two models of inflammation (imiquimod‐induced skin inflammation and delayed‐type hypersensitivity arthritis [ DTHA ]) were induced in TNFRII −/− mice, with or without transfer of purified CD 4+ CD 25+ cells from wild‐type ( WT ) mice. In patients with RA and those with SpA, the evolution of the TNFRII + Treg cell population before and after targeted treatment was monitored. Results Foxp3 gene methylation in Treg cells was greater in TNFRII −/− mice than in WT mice (50% versus 36.7%). In cultured Treg cells, TNF enhanced the expression, maintenance, and proliferation of Foxp3 through TNFRII signaling. Imiquimod‐induced skin inflammation and DTHA were aggravated in TNFRII −/− mice ( P &lt; 0.05 for mice with skin inflammation and P &lt; 0.0001 for mice with ankle swelling during DTHA compared to WT mice). Adoptive transfer of WT mouse Treg cells into TNFRII −/− mice prevented aggravation of arthritis. In patients with RA receiving anti‐ TNF treatments, but not those receiving tocilizumab, the frequency of TNFRII + Treg cells was increased at 3 months of treatment compared to baseline (mean ± SEM 65.2 ± 3.1% versus 49.1 ± 5.5%; P &lt; 0.01). In contrast, in anti‐ TNF –treated patients with SpA, the frequency of TNFRII + Treg cells was not modified. Conclusion TNFRII expression identifies a subset of Treg cells that are characterized by stable expression of Foxp3 via gene hypomethylation, and adoptive transfer of TNFRII ‐expressing Treg cells ameliorates inflammation in experimental models. Expansion and activation of TNFRII + Treg cells may be one of the mechanisms by which anti‐ TNF agents control inflammation in RA , but not in SpA.
Sequential Measurement of Bone Mineral Density Identifies Ongoing Recovery of Detrimental Bone Mass in Very Long Term Adult Survivors of Childhood Cancer
Authors: Bibi C. Klap, Mariël L. Te Winkel, Marjolein van Waas, Sebastiaan J.C.M.M Neggers, Annemieke M. Boot, Rob Pieters, Marry M. van den Heuvel-Eibrink
Journal: Blood (2012)
The Transcription Factor PU.1 Controls a Reversible Differentiation Program in Acute Myeloid Leukemia
Authors: Mark D McKenzie, Margherita Ghisi, Luisa Cimmino, Michael Erlichster, Ethan P Oxley, Cynthia Liu, Matthew T Witkowski, Grace Liu, Aleksandar Dakic, Emilia Simankowicz, Ladina DiRago, Donald Metcalf, Stephen L Nutt, Meaghan Wall, Matthew E Ritchie, Johannes Zuber, Ross A Dickins
Journal: Blood (2016)
US jury orders Johnson &amp; Johnson to pay $8bn to man with gynaecomastia linked to risperidone
Authors: Owen Dyer
Journal: BMJ (2019)

Johnson & Johnson and its subsidiary Janssen Pharmaceuticals have been ordered by a Philadelphia jury to pay $8bn (£6.5bn; €7.3bn) in punitive damages to Nicholas Murray, 26, who developed gynaecomastia while taking the atypical antipsychotic drug risperidone.

Risperidone (marketed in the US by Janssen as Risperdal) can increase concentrations of the hormone prolactin, causing breast development in boys and men.

Two different paediatricians prescribed the drug to Murray off label. He began taking it in 2003 when he was aged 9 for sleep disturbances associated with an autism spectrum disorder. He stopped five years later when the family became concerned about his developing breasts.

In 2013, aged 20, Murray sued Janssen, alleging that the company downplayed the risk of gynecomastia in its marketing to doctors and its application …
Overcoming p53 Loss with a Multi-Targeted Small Molecule Inhibitor in Multiple Myeloma.
Authors: Diana Cirstea, Teru Hideshima, Loredana Santo, Sonia Vallet, Samantha Pozzi, Kishan Patel, Hiroshi Ikeda, Hannes Loferer, Giulia Perrone, Gullu Gorgun, Yiguo Hu, Nikhil C. Munshi, Kenneth C. Anderson, Noopur Raje
Journal: Blood (2009)
N-Glycoproteomic Landscape of Human Lymphoid Cancers Reveals Novel Biomarkers and Potential Therapeutic Targets
Authors: Delphine CM Rolland, Venkatesha Basrur, Yoon Kyung Jeon, Carla McNeil-Schwalm, Damian Fermin, Kevin Conlon, Chih-Chiang Tsou, Noah A Brown, Dafydd G Thomas, Nathanael G. Bailey, Gilbert S Omenn, Alexey I Nesvizhskii, Megan S Lim, Kojo SJ Elenitoba-Johnson
Journal: Blood (2015)
The Use of RNA Sequencing to Identify Disease-Specific Gene Expression Signatures and Critical Regulatory Networks Across Hematologic Malignancies
Authors: Ashwini Kumar, Muntasir Mamun Majumder, Jesus María Lopez Martí, Alun Parsons, Pirkko Mattila, Kimmo Porkka, Olli Kallioniemi, Caroline A Heckman
Journal: Blood (2014)
Subset-Specific Spectra of Recurrent Gene Mutations in Chronic Lymphocytic Leukemia with Stereotyped B-Cell Receptors
Authors: Lesley-Ann Sutton, Emma Young, Panagiotis Baliakas, Anastasia Hadzidimitriou, Karla Plevova, Davide Rossi, Jitka Malcikova, Evangelia Stalika, Lone Bredo Pedersen, Andreas Agathangelidis, Zadie Davis, Larry Mansouri, Lydia Scarfò, Myriam Boudjogra, Alba Navarro, Alice Muggen, Xiao-Jie Yan, Panagiotis Panagiotidis, Nicholas Chiorazzi, Christian Geisler, Chrysoula Belessi, Elias Campo, Jonathan C. Strefford, Paolo Ghia, Anton W Langerak, David Oscier, Gianluca Gaidano, Sarka Pospisilova, Frederic Davi, Kostas Stamatopoulos, Richard Rosenquist
Journal: Blood (2014)
Integrative Genomic Analysis of Primary Plasma Cell Leukemia Revealed Strong Gene and MicroRNA Dosage Effect
Authors: Laura Mosca, Pellegrino Musto, Sonia Fabris, Katia Todoerti, Marta Lionetti, Luca Agnelli, Giacomo Tuana, Donata Verdelli, Paola Omedè, Vitina Grieco, Gabriella Bianchino, Fiorella D'Auria, Maria Teresa Petrucci, Fortunato Morabito, Francesco Nobile, Massimo Offidani, Francesco Di Raimondo, Nicola Cascavilla, Attilio Olivieri, Tommaso Caravita, Antonio Palumbo, Antonino Neri
Journal: Blood (2010)
Complementary Molecular Biology Techniques for the Detection of Unbalanced Chromosomal Abnormalities in Acute Myeloid Leukemias and Myelodysplastic Syndromes: Comparison of Fluorescence In Situ Hybridization (FISH) and Multiplex Ligation-Dependent Probe Amplification (MLPA)
Authors: Elvira D Rodrigues Pereira Velloso, Camila L Clozato, Mauren Fernanda Muller Santos, Maria Gabriella Cordeiro, Roberta Sitnik, Joao Renato R Pinho, Cristovao Luis P Mangueira
Journal: Blood (2016)
Cytogenetic Abnormalities In a Cohort of 171 Patients with Waldenström Macroglobulinemia Before Treatment: Clinical and Biological Correlations
Authors: Florence Nguyen-Khac, Julie Lejeune, Elise Chapiro, Aurore Grelier, Sarah Mould, Carole Barin, Agnes Daudignon, Nathalie Gachard, Stephanie Struski, Catherine Henry, Dominique Penther, Hossein Mossafa, Joris Andrieux, Lauren Veronese, Virginie Eclache, Chrystele Bilhou-Nabera, Isabelle Luquet, Christine Terré, Laurence Baranger, Francine Mugneret, marie-Jose Gregoire, Jean Chiesa, Sylvie Ramond, Marie-Joelle Mozziconacci, Evelyne Callet-Bauchu, Helene Merle-Beral, Véronique Leblond
Journal: Blood (2010)
Results from a Phase Ib Evaluation of Tazemetostat (EPZ-6438) in Combination with R-CHOP in Poor Prognosis Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL): a Lysa Study
Authors: Clementine Sarkozy, Franck Morschhauser, Jean-Marie Michot, Benjamin Suttle, Lionel Karlin, Steven LE Gouill, Fabrice Jardin, Herve Tilly, Charles Herbaux, Gilles Andre Salles, Vincent Ribrag
Journal: Blood (2018)
Genetic and Pharmacologic Notch4 Inhibition Synergizes with FLT3 Tyrosine Kinase Inhibition in Vitro to More Effectively Eliminate FLT3/ITD-Positive Leukemia Cells
Authors: Courtney M. Shirley, S. Haihua Chu, Yandan Yang, George W. Wright, Louis M. Staudt, Donald Small
Journal: Blood (2014)
Detailed Safety Analysis of Venetoclax Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Authors: Danielle M. Brander, Michael Y. Choi, Andrew W. Roberts, Shuo Ma, L. Leanne Lash, Maria Verdugo, Ming Zhu, Su Young Kim, John F Seymour
Journal: Blood (2016)
Error in Coding of Questionnaire Scale in Study of Depression in Adolescents
Authors: David A. Brent, Giovanna Porta
Journal: JAMA (2019)

Questionnaire Scale: In the Original Investigation entitled "Switching to Another SSRI or to Venlafaxine With or Without Cognitive Behavioral Therapy for Adolescents With SSRI-Resistant Depression: the TORDIA Randomized Controlled Trial," published in the February 27, 2008, issueof JAMA, 1 the coding used for the Suicidal Ideation Questionnaire-Jr was incorrect.The scale ranges from 0 to 6; we had coded the scores on a scale from 1 to 7, which inflated the total scores.The resulting means, CIs, and cut point for clinical significance were incorrect.The data in Table 1, the Results section, and Table 4 were affected, but the errors did not affect the conclusions or interpretations of the study.
Utility Of Non-Invasive Monitoring Of Circulating Tumor DNA At Diagnosis, Interim Therapy, and Relapse Of DLBCL Using High-Throughput Sequencing Of Immunoglobulin Genes
Authors: Michael R Green, Scott Bratman, Chih Long Liu, Kazuhiro Takahashi, Cynthia Glover, Colm Keane, Shingo Kihira, Katie Kong, Malek Faham, Corbelli Karen, David B. Miklos, Ranjana H. Advani, Ronald Levy, Mark S. Hertzberg, Frcpa Frcpa, Maher K Gandhi, Maximilian Diehn, Ash A. Alizadeh
Journal: Blood (2013)
Unrelated Cord Blood Transplantation For Infant Acute Leukemia Diagnosed Within 1 Year Of Age: Outcomes and Risk Factor Analysis On Behalf Of Eurocord and PDWP-EBMT
Authors: Annalisa Ruggeri, Fernanda Volt, Gerard Michel, Cristina Diaz de Heredia, Manuel Abecasis, Marco Zecca, Franco Locatelli, Ajay J. Vora, Karima Yakouben, Tracey O'Brien, Giorgio Dini, Jacqueline Cornish, Eliane Gluckman, Christina Peters, Vanderson Rocha, Jean-Hugues Dalle
Journal: Blood (2013)
Neurocognitive Trajectory of Patients with Childhood Cerebral Adrenoleukodystrophy Who Received Allogeneic Hematopoietic Cell Transplantation at an Early Stage of Cerebral Disease
Authors: Elizabeth Pierpont, Julie Eisengart, Richard Ziegler, Gerald Raymond, Paul J Orchard, Troy Lund, Weston P Miller
Journal: Blood (2016)
Frontline High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Stem Cell Transplantation Induces High Rates of Complete Response and Prolongs Survival in Mantle Cell Lymphoma (MCL).
Authors: Sergio Cortelazzo, Michele Magni, Milena Pintimalli, Michael Mian, Andrea Rossi, Atto Billio, Maddalena Marchesi, Manuela Zanni, Corrado Tarella, Mario Boccadoro, Angelo Andreini, Fabio Benedetti, Giovanni Pizzolo, Tiziano Barbui, Alessandro M. Gianni, Alessandro Rambaldi
Journal: Blood (2006)
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis
Authors: Karla Solo, Shahar Lavi, Conrad Kabali, Glenn N Levine, Alexander Kulik, Ava A John-Baptiste, Stephen E Fremes, Janet Martin, John W Eikelboom, Marc Ruel, Ashlay A Huitema, Tawfiq Choudhury, Deepak L Bhatt, Nikolaos Tzemos, Mamas A Mamas, Rodrigo Bagur
Journal: BMJ (2019)

Abstract Objective To assess the effects of different oral antithrombotic drugs that prevent saphenous vein graft failure in patients undergoing coronary artery bypass graft surgery. Design Systematic review and network meta-analysis. Data sources Medline, Embase, Web of Science, CINAHL, and the Cochrane Library from inception to 25 January 2019. Eligibility criteria for selecting studies Randomised controlled trials of participants (aged ≥18) who received oral antithrombotic drugs (antiplatelets or anticoagulants) to prevent saphenous vein graft failure after coronary artery bypass graft surgery. Main outcome measures The primary efficacy endpoint was saphenous vein graft failure and the primary safety endpoint was major bleeding. Secondary endpoints were myocardial infarction and death. Results This review identified 3266 citations, and 21 articles that related to 20 randomised controlled trials were included in the network meta-analysis. These 20 trials comprised 4803 participants and investigated nine different interventions (eight active and one placebo). Moderate certainty evidence supports the use of dual antiplatelet therapy with either aspirin plus ticagrelor (odds ratio 0.50, 95% confidence interval 0.31 to 0.79, number needed to treat 10) or aspirin plus clopidogrel (0.60, 0.42 to 0.86, 19) to reduce saphenous vein graft failure when compared with aspirin monotherapy. The study found no strong evidence of differences in major bleeding, myocardial infarction, and death among different antithrombotic therapies. The possibility of intransitivity could not be ruled out; however, between-trial heterogeneity and incoherence were low in all included analyses. Sensitivity analysis using per graft data did not change the effect estimates. Conclusions The results of this network meta-analysis suggest an important absolute benefit of adding ticagrelor or clopidogrel to aspirin to prevent saphenous vein graft failure after coronary artery bypass graft surgery. Dual antiplatelet therapy after surgery should be tailored to the patient by balancing the safety and efficacy profile of the drug intervention against important patient outcomes. Study registration PROSPERO registration number CRD42017065678.
IFNs Upregulate Sca-1 and Block Proliferation in Murine Hematopoietic Stem and Progenitor Cells,
Authors: Kaitlyn Shank, Yusup Shin, Carson Wills, Nicole Cunningham, Alevtina Domashenko, Russell Garrett, Jenni A. Punt, Stephen G. Emerson
Journal: Blood (2011)
Correction to: African evolutionary history inferred from whole genome sequence data of 44 indigenous African populations
Authors: Shaohua Fan, Derek E. Kelly, Marcia H. Beltrame, Matthew E. B. Hansen, Swapan Mallick, Alessia Ranciaro, Jibril Hirbo, Simon Thompson, William Beggs, Thomas Nyambo, Sabah A. Omar, Dawit Wolde Meskel, Gurja Belay, Alain Froment, Nick Patterson, David Reich, Sarah A. Tishkoff
Journal: Genome biology (2019)

Following publication of the original article [1], a typographical error in the formula for calculating d i in the “Scans for local adaptation” subsection in the Method section, was identified. The correct formula should be
New Early Prophylaxis Regimen That Avoids Immunological Danger Signals Can Reduce Factor Eight (FVIII) Inhibitor Development Independent From Product Type Used.
Authors: Guenter K.H. Auerswald, Christoph Bidlingmaier, Werner Engl, Heidi Chehadeh, Birgit M Reipert, Karin Kurnik
Journal: Blood (2009)
Typhoid Conjugate Vaccine Trial in Nepal: A Phase III Efficacy Analysis
Authors: M Shakya, R Colin-Jones, K Theiss-Nyland, M Voysey, D Pant, N Smith, X Liu, S Tonks, O Mazur, Y Mujadidi, J Clarke, J Hill, A Adhikari, S Dongol, A Karkey, B Bajracharya, S Kelly, M Gurung, S Baker, K Neuzil, S Shretha, B Basnyat, A Pollard
Journal: New England Journal of Medicine (2019)
Decitabine and Vitamin D3 Differentially Increase C-Jun, PU.1, and Sp1 Hematopoietic Transcription Factors To Induce Monocytic Differentiation.
Authors: Steffen Koschmieder, Shuchi Agrawal, Hanna S. Radomska, Claudia S. Huettner, Daniel G. Tenen, Oliver G. Ottmann, Wolfgang E. Berdel, Hubert L. Serve, Carsten Mueller-Tidow
Journal: Blood (2006)
An RNA-seq primer for pulmonologists
Authors: Sarah G. Chu, Sergio Poli De Frias, Benjamin A. Raby, Ivan O. Rosas
Journal: European Respiratory Journal (2019)

<b>RNA sequencing is a powerful tool for high-resolution transcriptomic analysis and can be leveraged to better understand the molecular underpinnings of diverse lung diseases</b>http://bit.ly/2mqBnl4
B-Aggressive Lymphoma Gene (BAL) Is a Risk-Related, γIFN-Inducible Gene That Is Expressed in Primary Diffuse Large B-Cell Lymphomas with a Brisk Host Inflammatory Response.
Authors: Przemyslaw Juszczynski, Jeffery L. Kutok, Ricardo C.T. Aguiar, Joydeep Mitra, Margaret A. Shipp
Journal: Blood (2004)
Expression of Mir-196b Is Not Exclusively MLL-Driven but Especially Linked to Activation of HOXA Genes in Children with Acute Lymphoblastic Leukemia.
Authors: Diana Schotte, Ellen Lange-Turenhout, Dominique JPM Stumpel, Ronald W. Stam, Jessica Buijs-Gladdines, Jules P.P. Meijerink, Rob Pieters, Monique L. Den Boer
Journal: Blood (2009)
Epo-Induced Erythroid Maturation Is Dependent On Plcγ1 Signalling
Authors: Tina M Schnoeder, Patricia Arreba-Tutusaus, Inga Griehl, Lars Bullinger, Konstanze Doehner, Christoph Plass, Daniel B Lipka, Florian H Heidel, Thomas Fischer
Journal: Blood (2013)
Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell: Proof of Concept and In Vivo Efficacy Results
Authors: Dipanjan Pan, Stephen Rogers, Santosh Misra, Gururaja Vulugundam, Lisa Gazdzinski, Albert Tsui, Nikhil Mistry, Ahmed Said, Philip Spinella, Greg Hare, Greg Lanza, Allan Doctor
Journal: Blood (2016)
Successful Management of a Left-Sided Endocarditis Patient Complicated with Hemophagocytic Lymphohistiocytosis---a Rare Case Report and Literature Review
Authors: Qiguo Zhang, Hui Zeng, Peipei Xu, Jing Wang, Ronggong Yang, Jingyan Xu, Rongfu Zhou, Jian Ouyan, Bing Chen
Journal: Blood (2016)
Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia (CMML): Prognostic Factors for Survival. A Report From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC),
Authors: Sophie Park, Myriam Labopin, Ibrahim Yakoub-Agha, Jacques Delaunay, Nathalie Dhedin, Agnes Buzyn, Eric Deconinck, Mauricette Michallet, Marie Robin, Thierry De Revel, Marc Bernard, Norbert Vey, Bruno Lioure, Simona Lapusan, Anne Sirvent, Reza Tabrizi, Jean-Henri Bourhis, Christian Recher, Yves Beguin, Pierre Fenaux, Mohamad Mohty
Journal: Blood (2011)
The Inhibition of the Osteoblast Niche during Hematopoietic Stem Cell Mobilization Is an Indirect Effect Involving Mature Bone Marrow Leukocytes, IL6 and Soluble IL6 Receptor.
Authors: Jean-Pierre Levesque, Ingrid G. Winkler, Natalie Sims, Howard Morris, Paul J. Simmons, Yasushi Takamatsu
Journal: Blood (2005)
High Serum Sclerostin Correlates with Advanced Stage, Increased Bone Resorption, Reduced Osteoblast Function, and Poor Survival in Newly-Diagnosed Patients with Multiple Myeloma.
Authors: Evangelos Terpos, Dimitrios Christoulas, Eirini Katodritou, Cornelia Bratengeier, Brigitte Lindner, Silvia Harmelin, Gerhard Hawa, Georgios Boutsikas, Magdalini Migkou, Maria Gavriatopoulou, Eurydiki Michalis, Anastasia Pouli, Efstathios Kastritis, Konstantinos Zervas, Meletios A. Dimopoulos
Journal: Blood (2009)
Resistant T-Cell Acute Lymphoblastic Leukemias That Emerge after In Vivo Treatment with Dexamethasone Frequently Down-Regulate Glucocorticoid Receptor Protein Expression
Authors: Anica M. Wandler, Benjamin Huang, Alessandro Scacchetti, Jeff Craig, Hannah Yan, Gabriela Monsalve, Qing Li, Monique Dail, Jasmine C. Wong, Joy Nakitandwe, Olga Weinberg, Robert P. Hasserjian, Scott C. Kogan, Deepak Sampath, James R. Downing, Keith Yamamoto, Barry S. Taylor, Jon C. Aster, Jinghui Zhang, Kevin Shannon
Journal: Blood (2016)
Multidisciplinary team Management System for Adverse Events Occurring in New Cancer Immunotherapies
Authors: Miki Kondo, Akiko Murayama, Kazue Hayasaka, Yukie Kimura, Kenichi Miyamoto, Hirohiko Yamauchi, Junichiro Yuda, Ryohei Serita, Yasutoshi Kuboki, Toshihiko Doi
Journal: Annals of Oncology (2019)
A Phase 3, Randomized, Placebo-Controlled Trial of Filgrastim in Patients (Pts) with Hematologic Malignancies (HM) Treated with a Myeloablative Conditioning Regimen and Allogenic Bone Marrow Transplantation (allo BMT).
Authors: P. Ernst, A. Bacigalupo, O. Ringdén, T. Ruutu, A. Zander, H. Kolb, W. Siegert, P. Strijckmans, F. Zwaan, T. Skacel
Journal: Blood (2005)
Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group
Authors: Julia Bohlius, Corinne Brillant, Michael Clarke, Sabine Kluge, Maryann Napoli, Margaret Piper, Dirk Rades, Isabelle Ray-Coquard, Kurt Schmidlin, Martin Schumacher, Guido Schwarzer, Jerome Seidenfeld, David P. Steensma, Sven Trelle, Michael Untch, Olaf Weingart, Marcel Zwahlen, Matthias Egger, Andreas Engert
Journal: Blood (2008)
A Young Case of Neoadjuvant Taxane Monotherapy for Breast Cancer toward pCR-Quadruple Neoplasms, Pairing Uterine Sarcoma
Authors: Yoko Nagata, Yoko Otani, Misato Hagi, Makiko Mizutani, Hiroyuki Yasojima, Kiyoshi Mori, Masayuki Manou, Ikuo Kudawara, Hisanori Matsumoto, Norikazu Masuda
Journal: Annals of Oncology (2019)
A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.
Authors: Beiming Shou, Baoan Chen, Dongrui Zhou, Jiahua Ding, Chong Gao, Yunyu Sun, Jun Wang, Jian Chen, Gang Zhao, Yan Ma, Huihui Song, Wen Bao, Xiaoping Pei, Xudong MA, Delong Liu
Journal: Blood (2007)
CBFA2T3-GLIS2 Fusion Is Prevalent in Younger Patients with Acute Myeloid Leukemia and Associated with High-Risk of Relapse and Poor Outcome: A Children’s Oncology Group Report
Authors: Heather L Schuback, Todd A. Alonzo, Robert B. Gerbing, Kristen L. Miller, Samir Kahwash, Amy Heerema-Mckenney, Betsy A. Hirsch, Susana C. Raimondi, Richard Aplenc, Alan S. Gamis, Soheil Meshinchi
Journal: Blood (2014)